Oramed Pharmaceuticals (ORMP) Stock Chart & Stock Price History $2.20 -0.01 (-0.45%) Closing price 04:00 PM EasternExtended Trading$2.19 -0.01 (-0.45%) As of 04:19 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Oramed Pharmaceuticals Stock Price Performance The Oramed Pharmaceuticals (ORMP) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has decreased 8.33%, with a year-to-date return of -9.09%. In the past month, the stock has decreased 0.45%, reflecting recent market activity. As of the latest close, Oramed Pharmaceuticals traded at $2.21 with a market cap of $90.61 million and volume of 96,020 shares. Five years ago, the stock traded at $3.46, representing a 36.42% decrease over that period. At the time, it had a market cap of $87.05 million and a volume of 40,600 shares. Receive ORMP Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Oramed Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. 5 Day Performance+2.80%1 Month Performance-0.45%3 Month Performance+1.85%Year-To-Date Performance-9.09%1 Year Performance-8.33%5 Year Performance-36.42% ORMP Stock Chart for Thursday, August, 28, 2025 ORMP Chart by TradingView Oramed Pharmaceuticals Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization08/28/2025$2.21$2.20-0.45%$2.21$2.1779,254 shs$90.21 million08/27/2025$2.12$2.21+4.25%$2.21$2.1196,020 shs$90.61 million08/26/2025$2.17$2.12-2.30%$2.16$2.1264,249 shs$86.92 million08/25/2025$2.14$2.17+1.40%$2.19$2.15181,001 shs$88.98 million08/22/2025$2.06$2.14+3.88%$2.15$2.0659,277 shs$87.75 million08/21/2025$2.07$2.06-0.48%$2.09$2.0652,840 shs$84.46 million08/20/2025$2.06$2.07+0.49%$2.08$2.0571,441 shs$84.87 million08/19/2025$2.08$2.06-0.96%$2.11$2.0670,840 shs$84.14 million08/18/2025$2.08$2.08$2.12$2.0584,470 shs$84.97 million08/15/2025$2.12$2.08-1.89%$2.12$1.98132,549 shs$84.97 million Get the Latest News and Ratings for ORMP and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Oramed Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 08/14/2025$2.12$2.12$2.14$2.0970,112 shs$86.60 million08/13/2025$2.10$2.12+0.95%$2.14$2.0952,897 shs$86.59 million08/12/2025$2.09$2.10+0.48%$2.11$2.0746,127 shs$85.79 million08/11/2025$2.09$2.09$2.10$2.0645,663 shs$85.38 million08/08/2025$2.08$2.09+0.48%$2.12$2.0936,346 shs$85.38 million08/07/2025$2.09$2.08-0.48%$2.13$2.0699,880 shs$84.96 million08/06/2025$2.08$2.09+0.48%$2.12$2.0836,669 shs$85.38 million08/05/2025$2.09$2.08-0.48%$2.12$2.0732,632 shs$84.97 million08/04/2025$2.12$2.09-1.42%$2.14$2.0875,410 shs$85.37 million08/01/2025$2.15$2.12-1.40%$2.18$2.0861,152 shs$86.60 million07/31/2025$2.13$2.15+0.94%$2.19$2.1194,636 shs$87.82 million07/30/2025$2.20$2.13-3.18%$2.21$2.1377,264 shs$87.01 million07/29/2025$2.21$2.20-0.45%$2.25$2.15127,642 shs$89.87 million07/28/2025$2.16$2.21+2.31%$2.26$2.1765,636 shs$90.27 million Related Companies 4D Molecular Therapeutics Stock Chart Inhibrx Biosciences Stock Chart Candel Therapeutics Stock Chart Larimar Therapeutics Stock Chart Rocket Pharmaceuticals Stock Chart Amarin Stock Chart Aldeyra Therapeutics Stock Chart Altimmune Stock Chart CytomX Therapeutics Stock Chart Canopy Growth Stock Chart Receive ORMP Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Oramed Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:ORMP) was last updated on 8/28/2025 by MarketBeat.com Staff From Our PartnersMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredElon’s BIGGEST warning yet?Tesla's About to Prove Everyone Wrong... Again Back in 2018, when Jeff Brown told everyone to buy Tesla… ...Brownstone Research | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredWhat Are Some Strategies to Help Lower RMD Taxes?Turning 73 triggers a key IRS rule: you must begin taking required minimum distributions (RMDs) from certain r...SmartAsset | SponsoredNVIDIA's Worst Nightmare?$2 TRILLION Quantum Gold Rush While everyone fights over expensive AI stocks... McKinsey just revealed the ...The Oxford Club | SponsoredThink you missed gold’s boom? Think againIf you've been watching gold's historic run and wondering if it's too late… I've got good news. Because the...Investors Alley | SponsoredTrump’s national nightmare is hereAI is no longer just about chatbots — it’s becoming the backbone of the global economy. While U.S. firms push ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Oramed Pharmaceuticals Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Oramed Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access